Loading...

CTEV CLARITEV CORP Legal Disputes 8-K Filing

CLRT

CTV

CLARITEV CORP

(CTEV)

2026 8-K

DOJ Investigation Update

Financial Results

Stockholder Meeting Results

Investor Day Update

Share Buyback Approval

Investor Presentation

Management Change

Stock Offering Details

Q3 Financial Results

Contract Renewals

Management Change

Investor Presentation

Financial Statements

Financial Statements

Amendment to Incentive Plan

Management Changes

Investor Presentation

Financial Results

Transformation Program

Debt Refinancing

Debt Restructuring

Management Change

Debt Restructuring

Q3 Financial Results

Capital Structure Review

Director Resignation

Stock Split Approval

Resignation and Appointment

Financial Results Announcement

Resignation of Executive

Financial Results Announcement

Appointment of Executive Vi...

Financial Results Announcement

Succession Plan Announcement

Financial Results Announcement

Meeting of Stockholders

Financial Results Announcement

Election of Director

Acquisition of Benefits Sci...

Financial Results Announcement

Annual Meeting of Stockholders

Compensation Changes

Settlement Agreement

Financial Results and Share...

Petition for Validation of ...

External Links:

Claritev Corp is facing a DOJ antitrust investigation initiated by a grand jury subpoena received in August 2024, but has not been deemed a target. This filing, dated May 18, 2026, indicates the company is cooperating with authorities while maintaining focus on healthcare improvements.

AI Assistant

CLARITEV CORP

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.